Influence of Inflammation and Aging on Macrophage Inhibitory Cytokine-1 Gene Expression in Rat Ventral Prostate

Urology

Volumn 73, Issue 2, 2009, Pages 410-414

  Taniguchi, Susumu ^a   Taoka, Rikiya ^a   Inui, Masashi ^a   Sugimoto, Mikio ^a   Kakehi, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH DIFFERENTIATION FACTOR 15; MESSENGER RNA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASTRATION; CELL INFILTRATION; CONTROLLED STUDY; EPITHELIUM; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; PROSTATITIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; STROMA;

AGE FACTORS; ANIMALS; GENE EXPRESSION; GROWTH DIFFERENTIATION FACTOR 15; MALE; PROSTATITIS; RATS; RATS, WISTAR;

EID: 58649107663     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.07.034     Document Type: Article

References (23)

1. McVary K.T. BPH: Epidemiology and comorbidities. Am J Manag Care 12 (2006) 122-128
2. Prakash K., Pirozzi G., Elashoff M., et al. Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays. Proc Natl Acad Sci USA 99 (2002) 7598-7603
3. Taoka R., Tsukuda F., Ishikawa M., et al. Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 (MIC-1) gene in symptomatic benign prostatic hyperplasia. J Urol 171 (2004) 2330-2335
4. Hromas R., Hufford M., Sutton J., et al. PLAB, a novel placental bone morphogenetic protein. Biochem Biophys Acta 1354 (1997) 40-44
5. Strelau J., Bottner M., Lingor P., et al. GDF-15/MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl 60 (2000) 273-276
6. Lawton L.N., Bonaldo M.F., Jelene P.C., et al. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 203 (1997) 17-26
7. Paralkar V.M., Vail A.L., Grasser W.A., et al. Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J Biol Chem 273 (1998) 13760-13767
8. Kakehi Y., Segawa T., Wu X.X., et al. Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia. Prostate 59 (2004) 351-356
9. Bootcov M.R., Bauskin A.R., Valenzuela S.M., et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94 (1997) 11514-11519
10. McConnell J.D., Roehrborn C.G., Bautista O.M., et al., Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349 (2003) 2387-2398
11. Stoker T.E., Robinette C.L., and Cooper R.L. Perinatal exposure to estrogenic compounds and the subsequent effects on the prostate of the adult rat: Evaluation of inflammation in the ventral and lateral lobes. Reprod Toxicol 13 (1999) 463-472
12. Wilson M.J., Woodson M., Wiehr C., et al. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat. Exp Mol Pathol 77 (2004) 7-17
13. Naslund M.J., Stranberg J.D., and Coffey D.S. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol 140 (1988) 1049-1053
14. Robinette C.L. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 12 (1988) 271-286
15. Kamijo T., Sato S., and Kitamura T. Effect of Cernitin pollen extract on experimental nonbacterial prostatitis in rats. Prostate 49 (2001) 122-131
16. Yamashita M., Zhang X., Shiraishi T., et al. Determination of percent area density of epithelial and stromal components in development of prostatic hyperplasia in spontaneously hypertensive rats. Urology 61 (2003) 484-489
17. Nickel J.C., Downey J., Young I., et al. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 84 (1999) 976-981
18. Kramer G., Steiner G.E., Handisurya A., et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52 (2002) 43-58
19. Steiner G., Gessl A., Kramer G., et al. Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia. J Urol 151 (1994) 480-484
20. Ho C., Nanda J., Chapman K.E., et al. Oestrogen and benign prostatic hyperplasia: Effects on stromal cell proliferation and local formation from androgen. J Endocrinol 197 (2008) 483-491
21. Zimmers T.A., Jin X., Hsiano E.C., et al. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 23 (2005) 543-548
22. Zimmers T.A., Jin X., Hisiao E.C., et al. Growth differentiation factor-15: Induction in liver injury through p53 and tumor necrosis factor-independent mechanism. J Surg Res 130 (2006) 45-51
23. Agarwal M.K., Hastak K., Jackson M.W., et al. Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors. Proc Natl Acad Sci USA 103 (2006) 16278-16283